Arzneimittel zur Verhinderung der Toleranzentwicklung während der Behandlung mit Benzodiazepin-Rezeptor-Bindenen Wirkstoffen
摘要
Described is the use of NMDA-receptor antagonists or physiologically tolerated salts thereof to prevent the development of tolerance during chronic treatment with benzodiazepine-receptor-binding substances. Also described is the combination of the new drugs with benzodiazepine-receptor-binding substances.
申请公布号
DE4222826(A1)
申请公布日期
1994.01.13
申请号
DE19924222826
申请日期
1992.07.09
申请人
SCHERING AG, 13353 BERLIN, DE
发明人
TURSKI, LECHOSLAW, DR., 1000 BERLIN, DE;STEPPUHN, KARIN GABRIELE, 1000 BERLIN, DE;SCHNEIDER, HERBERT, DR., 1000 BERLIN, DE;STEPHENS, DAVID NORMAN, DR., 1000 BERLIN, DE
